Regulatory Updates

Philippines: Draft Rules and Regulations on Clinical Investigations of Medical Devices and Clinical Performance Studies of IVD Medical Devices

The Philippine Food and Drug Administration (FDA) has released for public comment a Draft Administrative Order that will establish the rules and requirements for conducting Clinical Investigation (CI) of Medical Devices and Clinical Performance Studies (CPS) of In-Vitro Diagnostic (IVD) Medical Devices in the Philippines. Stakeholders are invited to submit

Thailand: Verification and Validation Guidelines for Alcohol-Containing Products Intended for Disinfecting Purposes for Humans, Animals, and Medical Devices

Following the Ministry of Public Health Notification B.E. 2562 (2019) regarding alcohol-containing products intended for disinfection of humans, animals, and medical devices, the Medical Device Control Division has undertaken a comprehensive review of such products. This review included the issuance of notification certificates and the evaluation of supporting documentation required

Philippines: Publication and Filing Details of DOH Administrative Order No. 2025-0030

The Philippines Department of Health has issued Administrative Order (AO) 2025-0030, formally adopting the Post-Marketing Alert System (PMAS) requirements under Annex 5 of the ASEAN Medical Device Directive (AMDD). This AO establishes the mandatory post-market surveillance framework for medical devices in the Philippines, ensuring continued safety, performance, and quality following

Philippines: Guidelines on the Use of the “eSUMBONG” System Within the New FDA Website

The Food and Drug Administration (FDA) has officially launched the eSUMBONG system, a new online reporting mechanism integrated into its updated website. This initiative marks a significant advancement in regulatory enforcement, providing the public with a streamlined and secure channel to lodge complaints or report violations concerning FDA-regulated products. By

Singapore: Software Medical Devices, IVDs, SAR and Registration Initiatives

The Health Sciences Authority (HSA) has introduced a series of regulatory initiatives aimed at strengthening oversight of medical devices while promoting innovation and timely patient access. The updates cover software and AI-enabled medical devices, dealer licensing requirements, regulatory reliance, IVD reclassification, and Special Access Route (SAR) registration initiatives. Read the

Sign up for our regulatory roundup delivered once a month to your inbox

Scroll to Top

Contact Us

Contact Form Demo

Don’t miss a single regulatory shift in Southeast Asia!

Subscribe to our Newsletter
Be the first to know about critical medical device regulation changes, market entry requirements, and industry shifts.

Subscription Form